CMS Backs Away From Expanding Carotid Stenting Coverage
This article was originally published in The Gray Sheet
Executive Summary
CMS has reversed its earlier proposal to significantly expand coverage of carotid stenting, dampening industry's hopes for a more open U.S. carotid stent market in the near term